Stay updated on Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-05-01T06:35:47.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study information regarding a clinical trial for abrocitinib and the addition of a new version revision and helpful links provided by Pfizer.
    Difference
    6%
    Check dated 2025-04-16T21:05:32.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T16:41:50.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-02T00:58:18.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The webpage has removed a notice regarding heavy traffic affecting NLM-NCBI services and a link to obtain contact information for a study center provided by Pfizer.
    Difference
    0.8%
    Check dated 2025-02-25T00:26:33.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.6%
    Check dated 2025-02-10T18:18:58.000Z thumbnail image

Stay in the know with updates to Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.